Wolverine Trading, LLC Mannkind Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $115,230 - $154,100	23,000 Added 34.33%	90,000 $565,000
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $37,260 - $49,956	9,200 Added 15.92%	67,000 $349,000
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $33,475 - $54,280	10,300 Added 21.68%	57,800 $261,000
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $43,086 - $55,341	12,900 Added 37.28%	47,500 $172,000
Q3 2023 Nov 15, 2023	BUY	$3.91 - $5.45 $135,286 - $188,570	34,600 New	34,600 $142,000
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $99,935 - $142,439	-25,300 Reduced 34.19%	48,700 $194,000
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $60,400 - $107,400	20,000 Added 37.04%	74,000 $390,000
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $161,460 - $234,899	54,000 New	54,000 $161,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $129,762 - $231,821	-48,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $30,916 - $52,510	11,800 Added 32.07%	48,600 $179,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $31,185 - $41,349	7,700 Added 26.46%	36,800 $161,000
Q3 2021 Nov 12, 2021	SELL	$3.89 - $5.48 $126,036 - $177,552	-32,400 Reduced 52.68%	29,100 $130,000
Q2 2021 Aug 06, 2021	BUY	$3.61 - $5.45 $139,346 - $210,370	38,600 Added 168.56%	61,500 $322,000
Q1 2021 May 14, 2021	SELL	$3.14 - $6.14 $120,576 - $235,776	-38,400 Reduced 62.64%	22,900 $84,000
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $69,631 - $157,156	38,900 Added 173.66%	61,300 $206,000
Q3 2020 Nov 13, 2020	BUY	$1.56 - $2.08 $1,404 - $1,872	900 Added 4.19%	22,400 $43,000
Q2 2020 Aug 13, 2020	SELL	$0.94 - $2.21 $15,040 - $35,360	-16,000 Reduced 42.67%	21,500 $39,000
Q1 2020 May 11, 2020	SELL	$0.84 - $1.76 $23,436 - $49,104	-27,900 Reduced 42.66%	37,500 $41,000
Q4 2019 Feb 12, 2020	BUY	$1.14 - $1.49 $74,556 - $97,446	65,400 New	65,400 $86,000
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $49,086 - $106,434	-48,600 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $372,323 - $620,540	-163,300 Reduced 77.06%	48,600 $111,000
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $326,040 - $959,530	143,000 Added 207.55%	211,900 $492,000
Q3 2017 Nov 15, 2017	BUY	$1.15 - $2.29 $79,235 - $157,781	68,900	68,900 $150,000

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.76B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account